TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group

This publication has 23 references indexed in Scilit:

• Frequency and Cost of Chemotherapy-Related Serious Adverse Effects in a Population Sample of Women With Breast Cancer
  JNCI Journal of the National Cancer Institute, 2006
• Symptom Clusters and Quality of Life in Survivors of Lung Cancer
  Oncology Nursing Forum, 2006
• Dealing With a Deluge of Data: An Assessment of Adverse Event Data on North Central Cancer Treatment Group Trials
  Journal of Clinical Oncology, 2005
• Phase III Study Comparing Cisplatin Plus Fluorouracil to Paclitaxel, Cisplatin, and Fluorouracil Induction Chemotherapy Followed by Chemoradiotherapy in Locally Advanced Head and Neck Cancer
  Journal of Clinical Oncology, 2005
• Concomitant Boost Radiation Plus Concurrent Cisplatin for Advanced Head and Neck Carcinomas: Radiation Therapy Oncology Group Phase II Trial 99-14
  Journal of Clinical Oncology, 2005
• Preliminary Results of Radiation Therapy Oncology Group 97-03: A Randomized Phase II Trial of Concurrent Radiation and Chemotherapy for Advanced Squamous Cell Carcinomas of the Head and Neck
  Journal of Clinical Oncology, 2004
• The Need for Adverse Effects Reporting Standards in Oncology Clinical Trials
  Journal of Clinical Oncology, 2004
• CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment
  Seminars in Radiation Oncology, 2003
• An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer
  Journal of Clinical Oncology, 2003
• Survey of Modalities of Toxicity Assessment and Reporting in Noncomparative Prospective Studies of Chemotherapy in Breast Cancer
  Journal of Clinical Oncology, 2002